Hallucinogen actions on human brain revealed
- PMID: 22308478
- PMCID: PMC3277578
- DOI: 10.1073/pnas.1121358109
Hallucinogen actions on human brain revealed
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3277578/bin/pnas.1121358109fig01.gif)
Comment on
-
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43. doi: 10.1073/pnas.1119598109. Epub 2012 Jan 23. Proc Natl Acad Sci U S A. 2012. PMID: 22308440 Free PMC article. Clinical Trial.
Similar articles
-
Psilocybin--summary of knowledge and new perspectives.Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17. Eur Neuropsychopharmacol. 2014. PMID: 24444771 Review.
-
Neuroimaging: a scanner, colourfully.Curr Biol. 2012 Apr 10;22(7):R231-3. doi: 10.1016/j.cub.2012.02.033. Curr Biol. 2012. PMID: 22497939
-
Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.Psychopharmacology (Berl). 1982;76(2):130-5. doi: 10.1007/BF00435266. Psychopharmacology (Berl). 1982. PMID: 6805022
-
A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.Curr Drug Abuse Rev. 2014;7(2):117-27. doi: 10.2174/1874473708666150107120930. Curr Drug Abuse Rev. 2014. PMID: 25563444 Clinical Trial.
-
Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.Prog Brain Res. 2018;242:159-177. doi: 10.1016/bs.pbr.2018.08.004. Epub 2018 Sep 28. Prog Brain Res. 2018. PMID: 30471679 Review.
Cited by
-
Dendritogenic Potential of the Ethanol Extract from Lippia alba Leaves in Rat Cortical Neurons.Molecules. 2023 Sep 16;28(18):6666. doi: 10.3390/molecules28186666. Molecules. 2023. PMID: 37764442 Free PMC article.
-
UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice.Neuropsychopharmacology. 2023 Nov;48(12):1798-1807. doi: 10.1038/s41386-023-01613-4. Epub 2023 May 29. Neuropsychopharmacology. 2023. PMID: 37248402
-
Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding.Transl Psychiatry. 2023 Apr 8;13(1):119. doi: 10.1038/s41398-023-02414-5. Transl Psychiatry. 2023. PMID: 37031219 Free PMC article.
-
Therapeutic use of psilocybin: Practical considerations for dosing and administration.Front Psychiatry. 2022 Dec 1;13:1040217. doi: 10.3389/fpsyt.2022.1040217. eCollection 2022. Front Psychiatry. 2022. PMID: 36532184 Free PMC article. Review.
-
Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists.J Med Chem. 2022 Sep 22;65(18):12031-12043. doi: 10.1021/acs.jmedchem.2c00702. Epub 2022 Sep 13. J Med Chem. 2022. PMID: 36099411 Free PMC article.
References
-
- Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;35:2505–2511. - PubMed
-
- González-Maeso J, et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 2007;53:439–452. - PubMed
-
- Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport. 1998;9:3897–3902. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical